Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Zevra Therapeutics
ISIN US4884452065
|WKN A2QLX7
Market cap (in EUR)
593 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States
Financials
Key metrics
| Market capitalisation, EUR | 593 m |
| EPS, EUR | 0.79 |
| P/B ratio | 3.2 |
| P/E ratio | 12.6 |
| Dividend yield | 0.00% |
Income statement (2025)
| Revenue, EUR | 94 m |
| Net income, EUR | 69 m |
| Profit margin | 72.87% |
What ETF is Zevra Therapeutics in?
There are 15 ETFs which contain Zevra Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Zevra Therapeutics is the L&G Pharma Breakthrough UCITS ETF.
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| iShares Russell 2000 Swap UCITS ETF USD (Acc) | 0.02% | Equity United States Small Cap | 52 |
| L&G Russell 2000 US Small Cap Quality UCITS ETF | 0.03% | Equity United States Small Cap | 190 |
| Xtrackers Russell 2000 UCITS ETF 1C | 0.02% | Equity United States Small Cap | 2,012 |
| Amundi Russell 2000 UCITS ETF EUR (C) | 0.02% | Equity United States Small Cap | 644 |
| Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD Acc | 0.02% | Equity United States Small Cap | 10 |
| Invesco Nasdaq Biotech UCITS ETF | 0.05% | Equity United States Health Care Biotech | 439 |
| iShares Russell 2000 Swap UCITS ETF EUR Hedged (Acc) | 0.02% | Equity United States Small Cap | 82 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.05% | Equity United States Health Care Biotech | 72 |
| Invesco Russell 2000 UCITS ETF Acc | 0.02% | Equity United States Small Cap | 300 |
| iShares Nasdaq US Biotechnology UCITS ETF | 0.05% | Equity United States Health Care Biotech | 1,049 |
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF EUR Hedged (Acc) | 0.02% | Equity United States Small Cap | 147 |
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF USD | 0.02% | Equity United States Small Cap | 4,236 |
| WisdomTree Russell 2000 | 0.02% | Equity United States Small Cap | 7 |
| L&G Pharma Breakthrough UCITS ETF | 2.97% | Equity World Health Care Innovation | 25 |
| Amundi Russell 2000 UCITS ETF USD | 0.02% | Equity United States Small Cap | 226 |
Savings plan offers
Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.
Detailed comparison of all offers
Source: justETF Research; as of 10/2026. The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded. In addition to the fees charged by online brokers, additional costs may apply. The stated fees are thus exclusive of standard market spreads, commissions, product costs and third-party fees. Please note: No guarantee can be given for the completeness, correctness and accuracy of the content listed. The information on the online brokers' homepages is decisive. Investments in securities involve risks.
*Affiliate link
** Important note: We are part of the Scalable Group since 2021 and are a wholly owned subsidiary of Scalable AG. This means that we are economically connected, but operate with editorial independence. Conflicts of interest are avoided because brokers — including Scalable — are evaluated according to uniform, objective criteria. You can view these in our transparent rating system. Ultimately, it’s up to you to decide how and with whom you want to invest.
*Affiliate link
** Important note: We are part of the Scalable Group since 2021 and are a wholly owned subsidiary of Scalable AG. This means that we are economically connected, but operate with editorial independence. Conflicts of interest are avoided because brokers — including Scalable — are evaluated according to uniform, objective criteria. You can view these in our transparent rating system. Ultimately, it’s up to you to decide how and with whom you want to invest.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information. (en-IT)